What a bit of competition will do to prices: prescription v. nonprescription drugs nhttps://t.co/O3KRUaHQ60 https://t.co/yQknZOWLoa
RT @PEWilliams_: At-cost projects should be another tool in the toolbox for public developers. Cross-subsidy, public vouchers, and at-cost…
RT @PEWilliams_: At-cost projects should be another tool in the toolbox for public developers. Cross-subsidy, public vouchers, and at-cost…